Content Style Guide - Substance: Difference between revisions
>White m Mind Control moved page Substance Page Style Guide to Talk:Substance Page Style Guide: It's not compelete yet |
>Unity patching |
||
| Line 17: | Line 17: | ||
# '''3-MeO-PCP''' (also known as '''3-MeO-PCP''', and '''3-MeO''') is a novel synthetic [[psychoactive class::dissociative]] substance of the [[chemical class::arylcyclohexylamine]] chemical class. It produces prominent [[dissociative|dissociating]], [[stimulating]] and [[hallucinogen]]ic effects when [[Routes of administration|administered]]. | # '''3-MeO-PCP''' (also known as '''3-MeO-PCP''', and '''3-MeO''') is a novel synthetic [[psychoactive class::dissociative]] substance of the [[chemical class::arylcyclohexylamine]] chemical class. It produces prominent [[dissociative|dissociating]], [[stimulating]] and [[hallucinogen]]ic effects when [[Routes of administration|administered]]. | ||
= | ==Intro template== | ||
====Introductory paragraph==== | |||
XXX (''[also vs. commonly]'' known as YYY or ZZZ) is a ''[naturally occurring vs. synthetic vs. semisynthetic] | XXX (''[also vs. commonly]'' known as YYY or ZZZ) is a ''[naturally occurring vs. synthetic vs. semisynthetic]'' ''[insert psychoactive class]'' substance of the ''[insert chemical class]'' chemical class. Like its ''[closely vs. ??? vs. blank related analogs XYZ, ABC and FUQ]'' it is ''[descriptor of popularity, like widely, or blank?]'' ''[known]'' for ''[its vs. producing vs. ability to produce]'' ''[descriptors of unusual potency, duration or other properties]'' A, B and C effects when administered. '''(Basic description and what it is known to do, or used for)''' | ||
====Brief history==== | |||
The compound was first synthesized in 1979 to investigate the structure-activity relationship of DZT derivatives. The activity of XXX in humans was not described until 1999 when a chemist using the pseudonym John Q. Beagle wrote that XXX was qualitatively similar to XX with comparable potency.[5] '''(History tidbit here, should these be standard if available?)''' | The compound was first synthesized in 1979 to investigate the structure-activity relationship of DZT derivatives. The activity of XXX in humans was not described until 1999 when a chemist using the pseudonym John Q. Beagle wrote that XXX was qualitatively similar to XX with comparable potency.[5] '''(History tidbit here, should these be standard if available?)''' | ||
====Unique/relevant info and pharmacology==== | |||
Like other substances of its class, particularly DAF and XCA, it primarily ''[induces vs. produces]'' a state referred to as "dissociative anesthesia", albeit the extent to which this occurs is highly dose-dependent and variable in effect.[citation needed] '''(Description of distinguishing properties compared to other substances?)''' Its most common routes of administration include oral, sublingual or nasal administration. '''(Remark on common RoAs necessary?)''' | |||
====Modern relevance==== | |||
''[In modern times vs. Today?]'' XXX is rarely sold on the streets and almost exclusively obtained as a gray area research chemical through the use of online vendors, where it is commonly used for recreational and, more ''[rarely and controversially]'' entheogenic purposes. '''(I like this as the standard closer, I think. Contains info on where it is obtained/used and what it is used for. Now how to word the last bit? All our substances are used recreationally, I think this only matters in this case?)''' | |||
====Warning and HR disclaimer (esp. if RC) ==== | |||
Due to its potent X and Y effects, reported habit-forming properties as well as unknown toxicity profile, it is strongly recommended that one use proper harm reduction practices if choosing to use this substance. | |||
==Chemistry template== | |||
==Pharmacology template== | |||
==Subjective effects template== | |||
==Toxicity and harm potential template== | |||
==Legal issues template== | |||
==See also template== | |||
==External links template== | |||
==Chemistry== | |||
==Pharmacology== | |||
==Subjective effects== | |||
==Toxicity and harm potential== | |||
==Legal issues== | |||
==See also== | |||
==External links== | |||
==References== | ==References== | ||
[[Category:Articles in talk page]] | [[Category:Articles in talk page]] | ||
Revision as of 21:32, 12 April 2017
type SPSG in search for easy access
post thoughtsm, this document is far from complete/
"is (said/believed/thought/known/shown/demonstrated) to produce..."
Opening Paragraph
Option one should be the default formatting for substances (one sentence). However, for substances with multiple effects of note, please resort to option two and the 2 sentence structure.
- X (also known as Y, and Z) is a (synthetic vs. naturally-occuring vs. semisynthetic) (insert psychoactive class) substance of the (insert chemical class) chemical class that produces Y effect when administered.
- X (also known as Y, and Z) is a (synthetic vs. naturally-occuring vs. semisynthetic) (insert psychoactive class) substance of the (insert chemical class) chemical class. It produces prominent X, Y and Z effects when administered.
Examples
- Lysergic acid diethylamide (also known as LSD, LSD-25, Lysergide, L, and Acid) is a widely used semisynthetic psychedelic substance of the lysergamide chemical class that produces what are considered "classical" psychedelic effects when administered.[citation needed]
- 3-MeO-PCP (also known as 3-MeO-PCP, and 3-MeO) is a novel synthetic dissociative substance of the arylcyclohexylamine chemical class. It produces prominent dissociating, stimulating and hallucinogenic effects when administered.
Intro template
Introductory paragraph
XXX ([also vs. commonly] known as YYY or ZZZ) is a [naturally occurring vs. synthetic vs. semisynthetic] [insert psychoactive class] substance of the [insert chemical class] chemical class. Like its [closely vs. ??? vs. blank related analogs XYZ, ABC and FUQ] it is [descriptor of popularity, like widely, or blank?] [known] for [its vs. producing vs. ability to produce] [descriptors of unusual potency, duration or other properties] A, B and C effects when administered. (Basic description and what it is known to do, or used for)
Brief history
The compound was first synthesized in 1979 to investigate the structure-activity relationship of DZT derivatives. The activity of XXX in humans was not described until 1999 when a chemist using the pseudonym John Q. Beagle wrote that XXX was qualitatively similar to XX with comparable potency.[5] (History tidbit here, should these be standard if available?)
Unique/relevant info and pharmacology
Like other substances of its class, particularly DAF and XCA, it primarily [induces vs. produces] a state referred to as "dissociative anesthesia", albeit the extent to which this occurs is highly dose-dependent and variable in effect.[citation needed] (Description of distinguishing properties compared to other substances?) Its most common routes of administration include oral, sublingual or nasal administration. (Remark on common RoAs necessary?)
Modern relevance
[In modern times vs. Today?] XXX is rarely sold on the streets and almost exclusively obtained as a gray area research chemical through the use of online vendors, where it is commonly used for recreational and, more [rarely and controversially] entheogenic purposes. (I like this as the standard closer, I think. Contains info on where it is obtained/used and what it is used for. Now how to word the last bit? All our substances are used recreationally, I think this only matters in this case?)
Warning and HR disclaimer (esp. if RC)
Due to its potent X and Y effects, reported habit-forming properties as well as unknown toxicity profile, it is strongly recommended that one use proper harm reduction practices if choosing to use this substance.